New York City Defective Drug Attorneys and Medical Malpractice Lawyers

We rely on medical professionals to provide good health care free from mistakes, negligence, or carelessness. Though many doctors and health care providers do provide us with excellent care, surgical mistakes, bad prescriptions, or misdiagnoses can sometimes occur leading to severe injury or, in some cases, death. At Proner & Proner in New York City, our team of medical malpractice and defective drugs lawyers will fight for your legal entitlements if you or a loved one was injured because of a doctor’s mistakes or the effects of a dangerous pharmaceutical.

Medical Malpractice

Medical malpractice is a familiar occurrence in heavily populated or major metropolitan areas such as New York City. Medical malpractice occurs when a patient suffers from a serious injury as a result of a medical professional’s mistakes or negligence. Some examples of potential medical malpractice lawsuits include cases in which a doctor makes an incorrect diagnosis, fails to treat a patient's condition promptly, issues a wrong prescription, or neglects to administer appropriate care. The medical malpractice victim and his or her family may be overwhelmed with medical bills as well as emotional pain and suffering. In the most severe medical malpractice cases, the patient might never be able to go back to work. In such situations, our medical malpractice lawyers in New York City can help you.

How Our Medical Malpractice Lawyers Can Help You

The legal team at Proner & Proner will investigate your medical malpractice claim and fight for each of your legal entitlements to ensure that you receive the just compensation you deserve. We will strive to win you the largest settlement possible in the shortest amount of time. It’s often the case that the statute of limitations (the time allowed to file a claim) is shorter in cases involving medical malpractice than ordinary negligence. After that time period expires, the medical malpractice patient is prohibited from seeking compensation for injuries sustained from medical malpractice. Each state has its own period of time in which to commence a medical malpractice lawsuit. This time period, however, is usually longer for cases involving children. Therefore, if you suspect that you or your loved one has been injured as a result of medical malpractice, it is important that you seek legal counsel quickly. If you need help from experienced medical malpractice lawyers based in New York City, contact Proner & Proner today.

Arava®
Baycol®
Celebrex®
Fen-Phen
Lotronex®
Meridia®
Oxycontin®
Paxil®
PPA
Prempro™
Rezulin®
Serzone®
Thimerosal
Vioxx®

Defective Drugs

New York City residents are fortunate to have defective drug attorneys Proner & Proner on their side. The pharmaceutical industry now spends billions of dollars every year to develop and market prescription and over-the-counter (OTC) drugs. Unfortunately, pharmaceutical companies sometimes fail to share all information about adverse effects of a drug, and as a result, physicians and consumers are not aware of the potential reactions that they might face. People are also sometimes harmed when their pharmacists improperly fill their prescriptions by either dispensing incorrect dosages, or even worse, the wrong prescription entirely. Other times, patients are permanently injured or worse, killed, by defective drugs. In New York City, Proner & Proner's talented defective drug lawyers represent clients who have been harmed by the following drugs:

How Our Defective Drug Lawyers Can Help You

Below is a list of various defective drugs and pharmaceuticals that have caused serious injuries and health problems. If you or someone you love has been harmed as a result of these defective or dangerous drugs, we encourage you to contact our medical malpractice lawyers in New York City. The defective drug lawyers of Proner & Proner will fight for the rights of patients and consumers. We will not be intimidated by large drug companies or manufacturers.

Arava®

Arava® is a drug used to treat rheumatoid arthritis. On March 29, 2002, the consumer group Public Citizen requested that the FDA ban Arava® due to its possible health risks. There have been 130 reports of liver damage among Arava® patients, and 22 deaths have occurred. In addition, Arava® can increase blood pressure and increase a patient's risk of stroke. Aventis, the manufacturer of Arava®, is considering strengthening the drug's warning labels, but Public Citizen wants the FDA to withdraw it. The FDA is currently taking Public Citizen's petition under advisement. For updated information about Arava®, visit www.fda.gov or contact our New York City defective drug and medical malpractice attorneys.

Baycol®

Baycol® belongs to a group of cholesterol drugs known as statins. All statin drugs are known to increase a person's risk of developing the rare muscle condition rhabdomyolysis, which causes damage to muscle cells. The injured cells then release a byproduct called myoglobin into the bloodstream. The presence of excessive myoglobin in the blood forces the kidneys to work harder than normal in order remove it. Rhabdomyolysis is not usually fatal. However, on August 8, 2001, Baycol® was recalled by its manufacturer, Bayer A.G. Pharmaceuticals. At the time of its recall, Baycol® had been associated with 31 deaths due to rhabdomyolysis in the United States and 52 deaths worldwide. For further information about Baycol®, visit www.fda.gov or contact our New York City defective drug attorneys.

Celebrex®

Celebrex® is a prescription arthritis drug. In February 2000, the FDA denied the request of Pharmacia and Pfizer, manufacturers of Celebrex®, to remove warning labels about the risk of serious stomach problems among Celebrex® patients. Although Celebrex® is intended to be easier on the stomach, at least 10 people have died of stomach complications while taking the drug and at least 11 others have been hospitalized due to gastrointestinal bleeding. In addition, questions about the cardiovascular safety of the Celebrex® rival, Vioxx®, have also brought into question the safety of Celebrex®. Some studies indicate Celebrex® patients have an increased likelihood of suffering from heart attacks, strokes, blood clots, and other heart-related problems. For up-to-date information about Celebrex®, visit www.fda.gov or speak with a member of our legal team.

Fen-Phen

Fen-phen was a popular diet drug until its 1997 recall. Fen-phen is actually a combination of either the drug fenfluramine or dexfenfluramine and phentermine. Fen-phen was recalled after both fenfluramine and dexfenfluramine were associated with heart valve damage and primary pulmonary hypertension (PPH). Over 100 cases of heart valve damage had been reported to the FDA when fen-phen was recalled. Approximately 30 percent of former fen-phen patients have some heart valve damage. PPH is a potentially fatal condition that restricts blood flow to the lungs and causes high blood pressure. For information regarding Fen-Phen, visit www.fda.gov or contact our medical malpractice lawyers in New York City.

Lotronex®

Lotronex® is a prescription medication that was used to treat irritable bowel syndrome (IBS) in women. In November 2000 – just nine months after the FDA approved the drug – Lotronex® was recalled. It was found to cause a potentially deadly condition called ischemic colitis (a serious intestinal inflammation) as well as severe constipation that required surgery in some cases. In total, eight deaths and 124 hospitalizations were reported to the FDA at the time of the Lotronex® recall. Glaxo Wellcome, Inc., manufacturer of Lotronex®, voluntarily recalled Lotronex® at the FDA's request but did not agree that the drug was dangerous. If you have been injured by Lotronex®, contact our medical malpractice and defective drug attorneys.

Meridia®

Meridia® is a prescription diet drug that has been used by many Americans to treat obesity. The safety of Meridia®, however, has recently been brought into question. On March 19, 2002, the consumer advocacy group Public Citizen asked the FDA to withdraw Meridia® from the market after 29 deaths among U.S. Meridia® patients had been reported. Most of the deaths were due to cardiovascular problems. In addition, at least 143 Meridia® patients have developed heart arrhythmia. Meridia® has already been recalled in Italy, where two people have died and many others have reported serious side effects. For updated information on Meridia®, visit www.fda.gov or contact our legal team today.

Oxycontin®

Oxycontin® is a prescription medication used for the relief of pain associated with serious injuries, cancer, and arthritis. An opium alkaloid, Oxycontin® can be highly addictive and along with pain relief, it can produce feelings of euphoria. For this reason, many people abuse Oxycontin®, subverting its time-release formula by crushing or dissolving the pill. According to the Drug Enforcement Agency, at least 282 people have died due to Oxycontin® abuse. Purdue Pharma manufactures Oxycontin®, and some people say that the company has not done enough to educate doctors and patients about the addictive nature of Oxycontin®. For up-to-date information about Oxycontin®, visit www.fda.gov or speak with one of our New York City defective drug attorneys.

Paxil®

Paxil® is a prescription drug used to treat depression, anxiety, and obsessive-compulsive disorder. It is a selective serotonin reuptake inhibitor (SSRI), and it works by regulating levels of the chemical serotonin in the brain (serotonin promotes feelings of calm and happiness). In December 2001, the FDA decided to add a warning to the Paxil® label about the risk of severe withdrawal symptoms in patients who stop taking Paxil®. Reported withdrawal symptoms include: nausea, depression, homicidal or suicidal feelings, anxiety, and sensory distortions. In many cases, the withdrawal symptoms are significantly worse than the original problem that was being treated with Paxil®. For current information on Paxil®, visit www.fda.gov or speak with one of our defective drug lawyers.

PPA

Phenylpropanolamine, or PPA, was an ingredient used in many over-the-counter cough and cold medications and diet pills. PPA's safety was brought into question by researchers at the Yale University School of Medicine, who found that PPA increases the risk of hemorrhagic stroke in women. As a result, the FDA asked manufacturers to remove PPA from their products in November 2000. To learn more about the dangers associated with PPA, visit www.fda.gov or speak with one of our skilled team of defective drug lawyers.

Prempro™

Prempro™ is a hormone replacement therapy (HRT) drug, used to treat the symptoms of menopause. A recent study of Prempro™ by the Women's Health Initiative was abruptly ended when it was found that women using the drug were subject to increased risk of heart disease, stroke, and breast cancer. For updated information on Prempro™, visit www.fda.gov or contact our New York City defective drug attorneys.

Rezulin®

Rezulin® is a drug used to regulate insulin and blood sugar levels in patients with type 2 diabetes. It was recalled on March 21, 2000. The FDA knew that Rezulin® could cause liver damage long before that date but hesitated to recall the drug because there were few alternative therapies available to the patients who depended on Rezulin®. Rezulin® was recalled soon after two new diabetes drugs became available, each of which was much safer than Rezulin®. Parke-Davis/Warner-Lambert, manufacturer of Rezulin®, complied with the FDA's request to remove Rezulin® from the market. For information regarding Rezulin® and Rezulin® risks, visit www.fda.gov or contact our defective drug and medical malpractice attorneys.

Serzone®

Serzone® is an antidepressant drug, manufactured by Bristol-Meyers Squibb. In December 2001, the FDA added a black box warning to the Serzone® label, because the drug can cause serious liver damage. The FDA has received reports of cases in which Serzone® patients have suffered liver failure that required a transplant. Some cases have been fatal. It is estimated that people taking Serzone® have a three to four times higher risk of liver damage than does the general population. In May of 2004, Serzone® was pulled from the U.S. market by Bristol-Meyers Squibb. For the latest information on Serzone®, visit www.fda.gov or speak with one of our New York City defective drug attorneys.

Thimerosal

Thimerosal is a mercury-containing preservative used in many vaccines since the 1930s. In 1997, the FDA recommended a gradual removal of thimerosal from vaccines because of concerns over its mercury content. Mercury can be harmful to humans, and some have speculated that thimerosal-containing vaccines may contribute to the development of autism in children. Although the theory is highly controversial, some parents of autistic children feel that there is a distinct connection between the time of their child's vaccinations and the appearance of autistic symptoms. To learn more about the dangers associated with thimerosal, visit www.fda.gov or speak with a member of our New York City legal team.

Vioxx®

When first released in 1999, millions of arthritis victims hailed the non-steroidal anti-inflammatory medication Vioxx® as a miracle. The drug proved highly effective for managing acute forms of pain. In 2000, a clinical trial was initiated to study the drug’s ability to prevent recurring colon polyps. While Vioxx® was found to successfully prevent the formation of new polyps, after 18 months, a significant number of the patients in the study developed cardiovascular problems. Twice as many Vioxx® recipients suffered heart attacks, strokes, or blood clots as those patients who received placebos. While the manufacturer of Vioxx®, Merck & Co., claims the risks posed by long term use of Vioxx® are relatively low, the company chose to voluntarily halt the clinical trial and remove the drug from all pharmacies on September 30, 2004. With as many as 80 million users worldwide, the Vioxx® travesty is considered one of the largest drug recalls in history. Merck's decision to remove Vioxx® from pharmacies is a relief, but for people who have used the medication since it was released five years ago, this action came too late. If you or a loved one has been injured or endured a cardiovascular event as a result of taking Vioxx®, contact our lawyers immediately for a consultation. For further information about Vioxx®, visit www.fda.gov or contact our defective drug attorneys.

Contact Our Medical Malpractice and Defective Drug Lawyers

At Proner & Proner, our team of New York City medical malpractice and defective drug lawyers is on your side. We always keep the best interests of our clients in mind and will fight to ensure you receive just compensation for pain and suffering, lost wages, serious injuries, further medical treatment, permanent disability, and other damages. To speak with a member of our legal team about your medical malpractice or defective drug case, contact Proner & Proner today.

Contact Proner and Proner, personal injury attorneys and auto accident lawyers based in New York City. They'll be in touch with you soon.

Free Case Review

Proner & Proner
60 E. 42nd Street
Suite 1448
New York, New York 10165

Phone :
1-800-PRO-LAW1
1-800-776-5291

Our auto accident lawyers or personal injury attorneys in New York City can help if you're in need of legal representation. Contact Proner and Proner. Our personal injury law firm will provide you with the representation you need and deserve.

Proner and Proner 60 E. 42nd Street Suite 1448 New York City, New York 10165 Ph: 1-800-776-5291